跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
安可坦 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Enzalutamide Soft Capsules
Approved
化学药品
Enzalutamide Soft Capsules
ASTELLAS PHARMA EUROPE B.V.
🇨🇳 National Medical Products Administration
Approval Date
Nov 18, 2019
Approval ID
7ucmdfugzfl
Company
ASTELLAS PHARMA EUROPE B.V.
Type
化学药品
Approval Details
Approval Id
7ucmdfugzfl
Approval Number
H20190056
Generic Name
恩扎卢胺软胶囊
Generic Name En
Enzalutamide Soft Capsules
Trade Name
安可坦
Brand Name
安可坦
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
40mg
Reg Date
2019-11-18
Expired Date
2024-11-17
Company Name
ASTELLAS PHARMA EUROPE B.V.
Company Address
Sylviusweg 62 2333 BE Leiden, The Netherlands.
Production Company Name
CATALENT PHARMA SOLUTIONS, LLC
Production Company Address
2725 Scherer Drive, St. Petersburg, FL 33716, USA.
Company Detail Path
/organization/astellas-pharma-europe-b-v
Production Company Detail Path
/organization/catalent-pharma-solutions-llc-madison-wisconsin-united-states
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 18, 2019
Approval ID
7ucmdfugzfl
Type
化学药品
Back to NMPA Approvals